Melphalan and Drug administration error - a phase IV clinical study of FDA data

Summary:

Drug administration error is reported as a side effect among people who take Melphalan (melphalan), especially for people who are male, 2-9 old, have been taking the drug for 6 - 12 months also take Busulfex, and have Neuroblastoma.

The phase IV clinical study analyzes which people have Drug administration error when taking Melphalan. It is created by eHealthMe based on reports of 20,050 people who have side effects when taking Melphalan from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Drug administration error?

Drug administration error is found to be associated with 1,017 drugs and 1,484 conditions by eHealthMe. Check the latest studies of Drug administration error.

On Jul, 11, 2026

20,050 people reported to have side effects when taking Melphalan.
Among them, 19 people (0.09%) have Drug administration error.

Could Melphalan cause Drug administration error?

Among these 19 people:

How long have people been on Melphalan when they have Drug administration error? *

What is the gender of people who have Drug administration error when taking Melphalan? *

female: 25 %
male: 75 %

What is the age of people who have Drug administration error when taking Melphalan? *

What are other drugs people take besides Melphalan? *

What are other side effects people have besides Drug administration error? *

Mucosal Inflammation (infection of mucous membrane): 8 people, 42.11%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 21.05%
Multi-Organ Failure (multisystem organ failure): 1 person, 5.26%
Diarrhea: 1 person, 5.26%
Disease Recurrence: 1 person, 5.26%
Drug Clearance Decreased: 1 person, 5.26%
Dyspnea (difficult or laboured breathing): 1 person, 5.26%
Enlarged Prostate: 1 person, 5.26%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 5.26%
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 1 person, 5.26%

What are the existing conditions these people have? *

Neuroblastoma (a cancer that forms in your nerve tissue): 3 people, 15.79%
Thromboembolism (obstruction of artery by blood clot): 1 person, 5.26%
Nicotine Dependence: 1 person, 5.26%
Myocardial Infarction Old (old destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle): 1 person, 5.26%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.26%
Mucous Membrane Disorder (disease of mucous membrane): 1 person, 5.26%
Hemiparesis (weakness on one side of the body): 1 person, 5.26%
Heart Attack: 1 person, 5.26%
Ewing's Sarcoma (malignant small, round, blue cell tumour): 1 person, 5.26%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and have Drug administration error?

- Check whether Drug administration error is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Melphalan:

Melphalan (20,052 reports)

Browse all side effects of Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug administration error:

Drug administration error (1,017 drugs)

Browse all the conditions that are associated with Drug administration error:

Drug administration error (1,484 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Melphalan) and Melphalan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.